Literature DB >> 21093114

Self-organizing molecular field analysis on human β-secretase nonpeptide inhibitors: 5, 5-disubstituted aminohydantoins.

Zhi Li1, Meng Zhou, Feng Wu, Rui Li, Zhenyu Ding.   

Abstract

5, 5-disubstituted aminohydantoins have been recently reported as potent and selective human β-secretase (BACE-1) inhibitors. Self-Organizing Molecular Field Analysis (SOMFA) is used to study the correlation between the molecular properties and biological activities of the 5, 5-disubstituted aminohydantoins inhibitors. Four different alignments and two charge-assigning methods were investigated. The model derived from the superposition of docked conformation with AM1 charge showed satisfied predictive ability, which has good non-cross-validated r(2) (0.842), cross-validated q(2) (0.792), F-test value (254.75) and satisfied predictive ability r(2)(pred) (0.721). Analysis of SOMFA model may provide some useful information in the design of BACE-1 inhibitors with better spectrum of activity.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21093114     DOI: 10.1016/j.ejmech.2010.10.014

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Hydrogen Bond Directed Photocatalytic Hydrodefluorination: Overcoming Electronic Control.

Authors:  Mohammad B Khaled; Roukaya K El Mokadem; Jimmie D Weaver
Journal:  J Am Chem Soc       Date:  2017-09-08       Impact factor: 15.419

2.  Hybrid approach to sieve out natural compounds against dual targets in Alzheimer's Disease.

Authors:  Sucharita Das; Sandipan Chakraborty; Soumalee Basu
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

3.  Combined 3D-QSAR modeling and molecular docking study on multi-acting quinazoline derivatives as HER2 kinase inhibitors.

Authors:  Sako Mirzaie; Majid Monajjemi; Mohammad Saeed Hakhamaneshi; Fardin Fathi; Mostafa Jamalan
Journal:  EXCLI J       Date:  2013-02-22       Impact factor: 4.068

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.